The Journal of Nutritional Biochemistry
Volume 18, Issue 8 , Pages 497-508 , August 2007

Vitamin A regulation of gene expression: molecular mechanism of a prototype gene

Received 10 July 2006 ,Revised 23 September 2006 ,Accepted 16 October 2006.

References 

  1. Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell. 1995;83:841–850
  2. Chambon P. A decade of molecular biology to retinoic acid receptors. FASEB J. 1996;10:940–954
  3. Laudet V, Gronemeyer H. Nuclear receptor factsbook. London: Academic Press; 2001;
  4. Mangelsdorf DJ, Thummel C, Reato M, Herrlich P, Schutz G, Umesono K, et al. The nuclear receptor superfamily: the second decade. Cell. 1995;83:835–839
  5. Heyman RA, Mandelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, et al. 9-Cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell. 1992;68:397–406
  6. Chambon P, Zelent A, Petkovich M, Mendelsohn C, Leroy P, Drust A, et al. The family of retinoic acid nuclear receptors. In:  Saurat JH editors. Retinoids: 10 years on. Basel: Karger; 1991;p. 10–27
  7. Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature. 1992;358:771–774
  8. Forman BM, Umesono K, Chen J, Evans RM. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell. 1995;81:541–550
  9. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, Mangelsdorf DJ. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 1995;9:1033–1045
  10. Perlman T, Rangarajan PN, Umesono K, Evans RM. Determinants for selective RAR and TR recognition of direct repeat HREs. Genes Dev. 1993;7:1411–1422
  11. Perlmann T, Jansson L. A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes Dev. 1995;9:769–782
  12. Mangelsdorf DJ, Borgmeyer U, Heyman RA, Zhou JY, Ong ES, Oro AE, et al. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev. 1992;6:329–344
  13. Aranda A, Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev. 2001;81:1269–1304
  14. Desvergne B, Michalik L, Wahli W. Transcriptional regulation of metabolism. Physiol Rev. 2006;86:465–514
  15. Luisi BF, Xu WX, Otwinowski A, Freedman LP, Yamamoto KR, Sigler PB. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature. 1991;352:497–505
  16. Lee MS, Kliewer SA, Provencal J, Wright PE, Evans RM. Structure of the retinoid X receptor alpha DNA binding domain: a helix required for homodimeric DNA binding. Science. 1993;260:1117–1121
  17. Schwabe JW, Chapman L, Finch JT, Rhodes D. The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell. 1993;75:567–578
  18. Chakravarti D, LaMorte VJ, Nelson MC, Nakajima T, Schulman IG, Juguilon H, et al. Role of CBP/p300 in nuclear receptor signalling. Nature. 1996;383:99–103
  19. Glass CK, Rosenfeld MG. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 2000;14:121–141
  20. Wurtz JM, Bourguet W, Renaud JP, Vivat V, Chambon P, Moras D, et al. A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol. 1996;3:87–94
  21. de The H, Vivanco-Ruiz MM, Tiollais P, Stunnenberg H, Dejean A. Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene. Nature. 1990;343:177–180
  22. Leid M, Kastner P, Chambon P. Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem Sci. 1992;17:427–433
  23. Rastinejad F, Wagner T, Zhao Q, Khorasanizadeh S. Structure of the RXR-RAR DNA-binding complex on the retinoic acid response element DR1. EMBO J. 2000;19:1045–1054
  24. Mangelsdorf DJ, Umesono K, Kliewer SA, Borgmeyer U, Ong ES, Evans RM. A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR. Cell. 1991;66:555–561
  25. Renaud JP, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H, et al. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature. 1995;378:681–689
  26. Moras D, Gronemeyer H. The nuclear receptor ligand-binding domain: structure and function. Curr Opin Cell Biol. 1998;10:384–391
  27. Onate SA, Boonyaratanakornkit V, Spencer TE, Tsai SY, Tsai MJ, Edwards DP, et al. The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors. J Biol Chem. 1998;273:12101–12108
  28. Nolte RT, Wisely GB, Westin S, Cobb JE, Lambert MH, Kurokawa R, et al. Ligand binding and coactivator assembly of the peroxisome proliferator-activated receptor gamma. Nature. 1998;395:137–143
  29. Darimont BD, Wagner RL, Apriletti JW, Stallcup MR, Kushner PJ, Baxter JD, et al. Structure and specificity of nuclear receptor–coactivator interactions. Genes Dev. 1998;12:3343–3356
  30. Heery DM, Kalkhoven E, Hoare S, Parker MG. A signature motif in transcriptional coactivators mediates binding to nuclear receptors. Nature. 1997;387:733–736
  31. Germain P, Iyer J, Zechel C, Gronemeyer H. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature. 2002;415:187–192
  32. Bannister AJ, Kouzarides T. The CBP-coactivator is a histone acetyltransferase. Nature. 1996;384:641–643
  33. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell. 1996;87:953–959
  34. Voegel JJ, Heine MJ, Tini M, Vivat V, Chambon P, Gronemeyer H. The coactivator TIF2 contains three nuclear receptor binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways. EMBO J. 1998;17:507–519
  35. McInerney EM, Rose DW, Flynn SE, Westin S, Mullen TM, Krones A, et al. Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes Dev. 1998;12:3357–3368
  36. Janknecht R, Hunter T. A growing coactivator network. Nature. 1996;383:22–23
  37. Chen JD. Steroid/nuclear receptor coactivators. Vitam Horm. 2000;58:391–448
  38. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, et al. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell. 1996;85:403–414
  39. Malik S, Roeder RG. Transcriptional regulation through mediator-like coactivators in yeast and metazoan cells. Trends Biochem Sci. 2000;25:277–283
  40. Cosma MP. Ordered recruitment: gene-specific mechanism of transcription activation. Mol Cell. 2002;10:227–236
  41. Cheung P, Allis CD, Sassone-Corsi P. Signaling to chromatin through histone modifications. Cell. 2000;103:263–271
  42. Orphanides G, Reinberg D. RNA polymerase II elongation through chromatin. Nature. 2000;407:471–475
  43. Dilworth FJ, Chambon P. Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription. Oncogene. 2001;20:3047–3054
  44. Adelman K, Lis JT. How does Pol II overcome the nucleosome barrier?. Mol Cell. 2002;9:451–452
  45. Fry CJ, Peterson CL. Chromatin remodeling enzymes: who's on first?. Curr Biol. 2001;11:R185–R197
  46. Aalfs JD, Kingston RE. What does chromatin remodeling mean?. Trends Biochem Sci. 2000;25:548–555
  47. Chen H, Evans R. A transcriptional corepressor that interacts with nuclear hormone receptors. Nature. 1995;377:454–457
  48. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor corepressor. Nature. 1995;377:397–404
  49. Dressel U, Thormeyer D, Altincicek B, Paulutat A, Eggert M, Schneider S, et al. Alien, a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily. Mol. Cell Biol. 1999;19:3383–3394
  50. Perissi V, Staszewski LM, McInerney EM, Kurokawa R, Krones R, Rose DW, et al. Molecular determinants of nuclear receptor–corepressor interaction. Genes Dev. 1999;13:3198–3208
  51. Ordentlich P, Downes M, Evans RM. Corepressors and nuclear hormone receptor function. Curr Top Microbiol Immunol. 2001;254:101–116
  52. Lavigne AC, Mengus G, Gangloff YG, Wurtz JM, Davidson I. Human TAF(II)55 interacts with the vitamin D(3) and thyroid hormone receptors and with derivatives of the retinoid X receptor that have altered transactivation properties. Mol Cell Biol. 1999;19:5486–5494
  53. Horwitz KB, Jackson TA, Bainm DL, Richer JK, Takimoto GS, Tung L. Nuclear receptor coactivators and corepressors. Mol Endocrinol. 1996;10:1167–1177
  54. Nagy L, Kao HY, Love JD, Li C, Banayo E, Gooch JT, et al. Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev. 1999;13:3209–3216
  55. Heinzel T, Tavinsky RM, Mullen TM, Soderstrom M, Laherty CD, Torchia J, et al. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature. 1997;387:43–48
  56. Alland L, Muhle R, Hou H, Potes J, Chin L, Schreiber-Agus N, et al. Role for NCoR and histone deacetylase in Sin3-mediatedd transcriptional repression. Nature. 1997;387:49–55
  57. Jones PL, Sachs LM, Rouse N, Wade PA, Shi Y-B. Multiple NCoR complexes contain distinct histone deacetylases. J Biol Chem. 2001;276:8807–8811
  58. Kouzarides T. Histone methylation in transcriptional control. Curr Opin Genet Dev. 2002;12:198–209
  59. Jenuwin T, Allis CD. Translating the histone code. Science. 2001;293:1074–1080
  60. Delva L, Bastie JN, Rochette-Egly C, Kraiba R, Balitrand N, Despouy G, et al. Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complex. Mol Cell Biol. 1999;19:7158–7167
  61. Dong D, Noy N. Heterodimer formation by retinoid X receptor: regulation by ligands and by the receptor's self-association properties. Biochemistry. 1998;37:10691–10700
  62. Budhu AS, Noy N. Direct channeling of retinoic acid between cellular retinoic acid-binding protein II and retinoic acid receptor sensitizes mammary carcinoma cells to retinoic acid-induced growth arrest. Mol Cell Biol. 2002;22:2632–2641
  63. Wang JC. The path of DNA in the nucleosome. Cell. 1982;29:724–726
  64. Richmond TJ, Finch JT, Rushton B, Rhodes D, Klug A. Structure of the nucleosome core particle at 7 A resolution. Nature. 1984;311:532–537
  65. Felsenfeld G, McGhee JD. Structure of the 30 nm chromatin fiber. Cell. 1986;44:375–377
  66. Chen H, Lin RJ, Xie W, Wilpitz D, Evans RM. Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell. 1999;98:675–686
  67. Strahl BD, Allis CD. The language of covalent histone modifications. Nature. 2000;403:41–45
  68. Roth SY, Denu JM, Allis CD. Histone acetyltransferases. Ann Rev Biochem. 2001;70:81–120
  69. Narlikar GJ, Fan HY, Kingston RE. Cooperation between complexes that regulate chromatin structure and transcription. Cell. 2002;108:475–487
  70. Ito M, Yuabn CX, Mallik S, Gu W, Fondell JD, Yamamura S, et al. Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. Mol Cell. 1999;3:361–370
  71. Woychik NA, Hampsey M. The RNA polymerase II machinery: structure illuminates function. Cell. 2002;108:453–463
  72. Kingston RE, Narlikar GJ. ATP-dependent remodeling and acetylation as regulators of chromatin fluidity. Genes Dev. 1999;13:2339–2352
  73. Delmotte MH, Tahayato A, Formstecher P, Lefebvre P. Serine 157, A retinoic acid receptor alpha residue phosphorylated by protein kinase C in vitro, is involved in RXR.RARalpha heterodimerization and transcriptional activity. J Biol Chem. 1999;274:38225–38231
  74. Rochette-Egly C. Nuclear receptors: integration of multiple signalling pathways through phosphorylation. Cell Signal. 2003;15:355–366
  75. Bastien J, Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene. 2004;328:1–16
  76. Rochette-Egly C, Oulad-Abdelghani M, Staub A, Pfister V, Scheuer I, Chambon P, et al. Phosphorylation of the retinoic acid receptor-alpha by protein kinase A. Mol Endocrinol. 1995;9:860–871
  77. Lee HY, Suh YA, Robinson MJ, Clifford JL, Hong WK, Woodgett JR, et al. Stress pathway activation induces phosphorylation of retinoid X receptor. J Biol Chem. 2000;275:32193–32199
  78. Matsushima-Nishiwaki R, Okuno M, Adachi S, Sano T, Akita K, Moriwaki H, et al. Phosphorylation of retinoid X receptor alpha at serine 260 impairs its metabolism and function in human hepatocellular carcinoma. Cancer Res. 2001;61:7675–7682
  79. Hong SH, Privalsky ML. The SMRT corepressor is regulated by a MEK-1 kinase pathway: inhibition of corepressor function is associated with SMRT phosphorylation and nuclear export. Mol Cell Biol. 2000;20:6612–6625
  80. Keriel A, Stary A, Sarasin A, Rochette-Egly C, Egly JM. XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARalpha. Cell. 2002;109:125–135
  81. Zhu J, Gianni M, Kopf E, Honore N, Chelbi-Alix M, Koken M, et al. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor a (RARa) and oncogenic RARa fusion proteins. Proc Natl Acad Sci U S A. 1999;96:14807–14812
  82. Kopf E, Plassat JL, Vivat V, de The H, Chambon P, Rochette-Egly C. Dimerization with retinoid X receptors and phosphorylation modulate the retinoic acid-induced degradation of retinoic acid receptors alpha and gamma through the ubiquitin–proteasome pathway. J Biol Chem. 2000;275:33280–33288
  83. Tanaka T, Rodriguez de la Concepcion ML, De Luca LM. Involvement of all-trans-retinoic acid in the breakdown of retinoic acid receptors alpha and gamma through proteasomes in MCF-7 human breast cancer cells. Biochem Pharmacol. 2001;61:1347–1355
  84. Conaway RC, Brower CS, Conaway JW. Emerging roles of ubiquitin in transcription regulation. Science. 2002;296:1254–1258
  85. Gianni M, Kopf E, Bastien J, Oulad-Abdelghani M, Garattini E, Chambon P, et al. Down-regulation of the phosphatidylinositol 3-kinase/Akt pathway is involved in retinoic acid-induced phosphorylation, degradation, and transcriptional activity of retinoic acid receptor gamma 2. J Biol Chem. 2002;277:24859–24862
  86. DeMartino GN, Slaughter CA. The proteasome, a novel protease regulated by multiple mechanisms. J Biol Chem. 1999;274:22123–22126
  87. Gianni M, Bauer A, Garattini E, Chambon P, Rochette-Egly C. Phosphorylation by p38MAPK and recruitment of SUG-1 are required for RA-induced RARg degradation and transactivation. EMBO J. 2002;21:3760–3769
  88. Gonzalez F, Delahodde A, Kodadek T, Johnston SA. Recruitment of a 19S proteasome subcomplex to an activated promoter. Science. 2002;296:548–550
  89. Muratani M, Tansey WP. How the ubiquitin–proteasome system controls transcription. Nat Rev Mol Cell Biol. 2003;4:192–201
  90. Zimmerman TL, Thevananther S, Ghose R, Burns AR, Karpen SJ. Nuclear export of retinoid X receptor alpha in response to interleukin-1beta-mediated cell signaling: roles for JNK and SER260. J Biol Chem. 2006;281:15434–15440
  91. Osburn DL, Shao G, Seidel HM, Schulman IG. Ligand-dependent degradation of retinoid X receptors does not require transcriptional activity or coactivator interactions. Mol Cell Biol. 2001;21:4909–4918
  92. Isseman I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 1990;347:645–650
  93. Dreyer C, Keller H, Mahfoudi A, Loudet V, Krey G, Wahli W. Positive regulation of peroxisomal β-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors. Biol Cell. 1993;77:67–77
  94. Tonotoz P, Hu E, Speigelman BM. Stimulation of adipogenesis in fibroblasts by PPAR gamma2, a lipid activated transcription factor. Cell. 1994;79L:1147–1156
  95. Osumi T, Wen JK, Hashimoto T. Two cis-acting elements in the peroxisome proliferators-responsive element enhancer region of rat acyl-CoA oxidase gene. Biochem Biophys Res Commun. 1991;175:866–871
  96. Tugwood JD, Isseman I, Anderson RG, Bundell KR, McPheat WL, Green S. The mouse peroxisome proliferators activated receptor recognizes a response element in the 5′-flanking sequence of rat acyl coA oxidase. Embo J. 1992;11:433–439
  97. Zhang X-K, Lehmann J, Hoffman B, Dawson M, Camerson J, Graupner G, et al. Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid. Nature. 1992;358:587–591
  98. Desvergne B, Wahli W. Peroxisome proliferators-activated receptors: nuclear control of metabolism. Endocr Rev. 1999;20:649–688
  99. Reddy JK. Peroxisome proliferators and peroxisome proliferator-activated receptor alpha. Am J Pathol. 2004;164:2305–2321
  100. Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature. 1995;375:377–382
  101. Egea PF, Rochel N, Birck C, Vachette P, Timmins PA, Moras D. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR. J Mol Biol. 2001;307:557–576
  102. Jump DB, Botolin D, Wang Y, Xu J, Christian B, Demeure O. Fatty acid regulation of hepatic gene transcription. J Nutr. 2005;135:2503–2506
  103. Yang W, Rachez C, Freedman LP. Discrete roles for peroxisome proliferators-activated receptor gamma and retinoid X receptor in recruiting nuclear receptor coactivators. Mol Cell Biol. 2000;20:8008–8017
  104. Ijpenberg A, Tan NS, Gelman L, Kersten S, Seydoux J, Xu J, et al. Polarity and specific sequence requirements of peroxisome proliferators-activated receptor/retinoid X receptor heterodimer binding to DNA. A functional analysis of the malic enzyme gene PPAR response element. Embo J. 2004;23:2083–2091
  105. Balmer JE, Blomhoff R. Gene expression regulation by retinoic acid. J Lipid Res. 2002;43:1773–1808
  106. Granner DK, Andreone T, Sasaki K, Beale E. Inhibition of transcription of the phosphoenolpyruvate carboxykinase gene by insulin. Nature. 1983;305:549–551
  107. Imai E, Stromstedt PE, Quinn PD, Carlstedt-Duke J, Gustafsson J, Granner DK. Characterization of a complex glucocorticoid response unit in the phosphoneolpyruvate carboxyukinase gene. Mol Cell Biol. 1990;10:4712–4719
  108. Lamers WH, Hanson RW, Meisner HM. cAMP stimulates transcription of the gene for cytosolic phosphoenolpuriuvate carboxykinase in rat liver nuclei. Proc Natl Acad Sci U S A. 1982;79:5137–5141
  109. McGrane MM, Yun JS, Moorman AF, Lamers WH, Hendrick GK, Arafah BM, et al. Metabolic effects of developmental, tissue- and cell-specific expression of a chimeric phosphoenolpyruvate carboxykinase (GTP)/bovine growth hormone gene in transgenic mice. J Biol Chem. 1990;265:22371–22379
  110. McGrane MM, Hanson RW. From diet to DNA: dietary patterning of gene expression. Nutr Clin Pract. 1992;7:16–21
  111. O'Brien RM, Lucas PC, Forest CD, Magnuson MA, Granner DK. Identification of a sequence in the PEPCK gene that mediates a negative effect of insulin on transcription. Science. 1990;249:533–537
  112. Sasaki K, Cripe TP, Kocks SR, Adreone TL, Petersen DD, Bealse EG, et al. Multihormonal regulation of phosphoenolpyruvate carboxykinasse gene transcription. J Biol Chem. 1984;259:8288–8292
  113. Short JM, Wynshaw-Boris A, Short HP, Hanson RW. Characterization of phosphoenolpyruvate carboxykinase (GTP) promoter-regulatory region. J Biol Chem. 1986;261:9721–9726
  114. Hall RK, Scott DK, Noisin EL, Lucas PC, Granner DK. Activation of the phosphoenolpyruvate carboxykinase gene retinoic acid response element is dependent on a retinoic acid receptor/coregulator complex. Mol Cell Biol. 1992;12:5527–5535
  115. Lucas PC, O'Brien RM, Mitchell JA, Davis CM, Imai E, Forman BM, et al. A retinoic acid response element is part of a pleiotropic domain in the phosphoenolpyruvate carboxykinase gene. Proc Natl Acad Sci U S A. 1991;88:2184
  116. Lucas PC, Forman BM, Samuels HH, Granner DK. Specificity of a retinoic acid response element in the phosphoenolpyruvate carboxykinase gene promoter: consequences of both retinoic acid and thyroid hormone receptor binding. Mol Cell Biol. 1991;11:5164–5170
  117. Scott DK, Mitchell JA, Granner KD. Identification and characterization of a second retinoic acid response element in the phosphoenolpyruvate carboxykinase gene promoter. J Biol Chem. 1996;271:6260–6264
  118. Devine JH, Eubank DW, Clouthier DE, Tontonoz P, Spiegelman BM, Hammer RE, et al. Adipose expression of the phosphoenolpyruvate carboxykinase promoter requires peroxisome proliferators-activated receptor gamma and 9-cis retinoic acid receptor binding to an adipocyte-specific enhancer in vivo. J Biol Chem. 1999;274:13604–13612
  119. Shin D-J, McGrane MM. Vitamin A regulates genes involved in hepatic gluconeogenesis in mice: phosphoenolpyruvate carboxykinase, fructose-1,6-bisphosphatase and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. J Nutr. 1997;127:1274–1278
  120. Shin D-J, Odom DP, Scribner KB, Ghoshal S, McGrane MM. Retinoid regulation of the phosphoenolpyruvate carboxykinase gene in liver. Mol Cell Endocrinol. 2002;195:39–54
  121. Scribner KB, Odom DP, McGrane MM. Nuclear receptor binding to the retinoic acid response elements of the phosphoenolpyruvate carboxykinase gene in vivo: effects of vitamin A deficiency. J Nutr Biochem. 2006;
  122. Eubank DW, Duplus E, Williams SC, Forest C, Beale EG. Peroxisome proliferator-activated receptor gamma and chicken ovalbumin upstream promoter transcription factor II negatively regulate the phosphoenolpyruvate carboxykinase promoter via a common element. J Biol Chem. 2001;276:30561–30569
  123. Leone TC, Weinheimer CJ, Kelly DP. A critical role for PPAR in the cellular fasting response: the PPAR alpha null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci U S A. 1999;96:7473–7477
  124. Xu J, Xiao G, Trujillo C, Chang V, Blanco L, Joseph SB, et al. PPARalppha influences substrate utilization for hepatic glucose production. J Biol Chem. 2002;277:50237–50244
  125. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W. Roles of PPARs in health and disease. J Clin Invest. 1999;103:1489–1498
  126. Scribner KB, Odom DP, McGrane MM. Vitamin A status in mice affects the histone code of the phosphoenolpyruvate carboxykinase gene in liver. J Nutr. 2005;135:2774–2779
  127. Puigserver P, Adelmant G, Wu Z, Fan M, Xu J, O'Malley B, et al. Activation of PPARgamma coactivator 1 through transcription factor socking. Science. 1999;286:1368–1371
  128. Monsalve M, Wu Z, Adelmant G, Puigserver P, Fan M, Spiegelman BM. Direct coupling of transcription and mRNA processing through the thermogenic coactivator PGC-1. Mol Cell. 2002;6(2):307–316
  129. Rhee J, Inoue Y, Yoon JC, Puigserver P, Fan M, Gonzales FJ, et al. Regulation of hepatic fasting response by PPARgamma coactivator 1 alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. Proc Natl Acad Sci U S A. 2003;100:4012–4017
  130. Hebbes TR, Thorne AW, Crane-Robinson C. A direct link between core histone acetylation and transcriptionally active chromatin. Embo J. 1988;7:1395–1402
  131. Edmondson DG, Davie JK, Zhou J, Mirnikjoo B, Tatchell K, Dent SYR. Site specific loss of acetylation upon phosphorylation of histone H3. J Biol Chem. 2002;277:29496–29502
  132. Kuo M-H, Brownell JE, Sobel RE, Ranalli TA, Cook RG, Edmondson DG, et al. Transcription-linked acetylation by Gcn5p of histones H3 and H4 at specific lysines. Nature. 1996;383:269–272
  133. Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, et al. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell. 1997;90:569–580
  134. Zhang W, Bieker JJ. Acetylation and modulation of erythroid druppel-like factor activity by interaction with histone acetyltransferases. Proc Natl Acad Sci U S A. 1998;95:9855–9860
  135. Grant PA, Eberharter A, John S, Cook RG, Turner BM, Workman JL. Expanded lysine acetylation specificity of Gcn5 in native complexes. J Biol Chem. 1999;274:5895–5900
  136. Spencer TE, Jenster G, Burcin MM, Allis CD, Zhou J, Mizzen C, et al. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature. 1997;389:9498
  137. Schiltz RL, Mizzen CA, Vassilev A, Cook RG, Allis CD, Nakatani Y. Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates. J Biol Chem. 1999;274:1189–1192
  138. Ito K, Barnes PJ, Adcock IM. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol. 2000;20:6891–6903
  139. Xu J, Li Q. Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol Endocrinol. 2003;17:1681–1692
  140. Soutoglou E, Katrakili N, Talianidis I. Acetylation regulates transcription factor activity at multiple levels. Mol Cell. 2000;5:745–751
  141. Scribner KB, McGrane MM. RNA polymerase II association with the phosphoenolpyruvate carboxykinase (PEPCK) promoter is reduced in vitamin A deficient liver. J Nutr. 2003;133:4112–4117
  142. Duong DT, Waltner-Law ME, Sears R, Sealy L, Granner DK. Insulin inhibits hepatocellular glucose production by utilizing liver-enriched transcriptional inhibitory protein to disrupt the association of CREB-binding protein and RNA polymerase II with the phosphoenolpyruvate carboxykinase gene promoter. J Biol Chem. 2002;277:32234–32242

PII: S0955-2863(06)00265-8

doi: 10.1016/j.jnutbio.2006.10.006

The Journal of Nutritional Biochemistry
Volume 18, Issue 8 , Pages 497-508 , August 2007

Article Tools

* Image Usage & Resolution